JPMORGAN CHASE & CO - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 65 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$51,615
-48.7%
22,441
-18.6%
0.00%
Q2 2023$100,67027,581
+70620.5%
0.00%
Q1 2023$0390.0%0.00%
Q4 2022$0390.0%0.00%
Q3 2022$0390.0%0.00%
Q2 2022$0
-100.0%
39
-99.7%
0.00%
Q1 2022$71,000
-47.8%
14,591
+21.1%
0.00%
Q4 2021$136,000
-19.0%
12,045
+4.4%
0.00%
Q3 2021$168,000
+24.4%
11,535
-0.5%
0.00%
Q2 2021$135,000
-0.7%
11,589
+3.8%
0.00%
Q1 2021$136,000
-17.6%
11,162
-15.0%
0.00%
Q4 2020$165,0000.0%13,125
+22.4%
0.00%
Q3 2020$165,000
-27.9%
10,726
+14.8%
0.00%
Q2 2020$229,000
+146.2%
9,342
+42.3%
0.00%
Q1 2020$93,000
-13.9%
6,564
-3.7%
0.00%
Q4 2019$108,000
+100.0%
6,814
+6.0%
0.00%
Q3 2019$54,000
+42.1%
6,427
+29.7%
0.00%
Q2 2019$38,000
+15.2%
4,956
+14.9%
0.00%
Q1 2019$33,000
+57.1%
4,313
-4.5%
0.00%
Q4 2018$21,000
-43.2%
4,516
+10.3%
0.00%
Q3 2018$37,000
-14.0%
4,094
+14.0%
0.00%
Q2 2018$43,000
+72.0%
3,590
+100.0%
0.00%
Q1 2018$25,0001,7950.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders